Skip to main content
. Author manuscript; available in PMC: 2014 Jan 20.
Published in final edited form as: J Med Virol. 2013 Apr 16;85(7):1139–1147. doi: 10.1002/jmv.23572

TABLE II.

Transmitted Drug Resistance Mutations (TDRs) by Antiretroviral Drug Class

Patients NRTIs NNRTIs PIs Subtype
1 L210W None None F1
2 M41L None None F1
3 K219Q None None F1
4 None None M46L C
5 M184V V179F, Y181C None F1
6 D67N, T69D, K70R, L74I, M184V, T215F, K219Q None L24I, M46I, I47V, F53L, I54V, V82A F1
7 K70R None None F1
8 D67N, K70R, T215F, K219Q V106M, Y188C None F1
9 M184V None None F1

NRTIs, nucleoside reverse-transcriptase inhibitors; NNRTIs, non-nucleoside reverse-transcriptase inhibitors; PIs, protease inhibitors.